What Is the Purpose of the Orphan Drug Act?
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.It may be time to reconsider the U.S. Orphan Drug Act. This law provides incentives for developing drugs for rare diseases, but its original purpose may need re-evaluation.
Area Of Science
- Health Law
- Pharmaceutical Policy
- Drug Development
Background
- The U.S. Orphan Drug Act (ODA) was enacted in 1983 to incentivize the development of drugs for rare diseases.
- The act provides incentives such as market exclusivity and tax credits to pharmaceutical companies.
- The landscape of rare disease drug development has evolved significantly since the ODA's inception.
Purpose Of The Study
- To critically examine the original intent and current application of the U.S. Orphan Drug Act.
- To assess whether the act's provisions remain effective in promoting orphan drug development.
- To explore potential areas for re-evaluation or reform of the Orphan Drug Act.
Main Methods
- Literature review of the Orphan Drug Act and its legislative history.
- Analysis of pharmaceutical industry trends and orphan drug approvals.
- Examination of policy critiques and scholarly discussions regarding the ODA.
Main Results
- The ODA has successfully stimulated the development of drugs for rare diseases.
- Questions have been raised about the act's broad application and potential for unintended consequences.
- The effectiveness and purpose of the ODA warrant ongoing discussion and potential revision.
Conclusions
- The U.S. Orphan Drug Act has been instrumental in advancing orphan drug development.
- A re-examination of the ODA's purpose and implementation is suggested in light of current scientific and market realities.
- Policy adjustments may be necessary to ensure the ODA continues to meet its objectives efficiently and equitably.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
During the development of a new pharmaceutical, the manufacturer initially assigns a code name to the drug. Once approved, the drug receives a United States Adopted Name (USAN)—a generic, nonproprietary designation. Upon being listed in the United States Pharmacopeia, this nonproprietary name becomes the drug's official name. Additionally, the manufacturer assigns a proprietary name or trademark, which serves as the brand name under which the drug is marketed. It is worth noting that...
Biologics, derived from living sources such as humans, animals, or microorganisms, represent a significant category of pharmaceuticals. These complex molecules, developed through advanced biotechnological methods or purified from natural sources, include essential medical treatments like insulin and growth hormones. The complexity of biologics arises from their large molecular structures and the intricate processes required for their production, making them distinct from conventional...
Prodrugs are a class of pharmaceutical compounds that undergo a biotransformation process within the body to be converted into a pharmacologically active drug. Prodrugs are designed to improve the therapeutic properties of the parent drug, such as enhancing bioavailability, increasing stability, or reducing toxicity. The concept of prodrugs revolves around modifying the chemical structure of the original drug to make it more effective or convenient for administration.
Prodrugs help overcome...
Post-approval, manufacturers may modify an approved new or generic drug product. Such modifications can encompass alterations in the Active Pharmaceutical Ingredient (API), manufacturing process, formulation, batch size, manufacturing site, and container closure system (FDA Guidance for Industry, April 2004). Often, a drug product may undergo multiple changes.These modifications require careful evaluation to determine their potential impact on the drug product's identity, strength, quality,...